Photoactivatable ligand tools for CXCR4 and ACKR3
Early stage researcher 1 (ESR1) project
Supervision: Prof. Dr. Rob Leurs, Prof. Dr. Iwan de Esch, Dr. Maikel Wijtmans
Host: Vrije Universiteit Amsterdam
I- Project proposal:
Aim:
The project aims for the design, synthesis and photochemistry of novel photoswitchable ligands for the CXCR4 and ACKR3 chemokine receptors.
Methodology:
This project will entail the design, synthesis and photochemical characterization of photoswitchable small-molecule CXCR4 and ACKR3 ligands. A wide variety of chemical transformations, synthetic equipment and photochemical techniques will be employed to generate and analyze the ligands. The design of any new ligands can be supported by computer-aided drug design studies where necessary. In vitro and in vivo pharmacological assays on the ligands will be conducted by fellow ESR7.
Planned secondments:
Heptares – the candidate will use modelling for characterizing the binding site of developed tools in CXCR4 X-ray structure and ACKR3 models.
University Hospital Jena – the candidate will work on in vitro characterization of photoswitchable compounds using single cell microscopy methodology.
II – Requirement candidate:
Required diploma: A MSc degree in Chemistry (or related field) with a specialization in Synthetic Organic Chemistry and/or Synthetic Medicinal Chemistry.
Required expertise: Experience in the design and synthesis of biologically active compounds is a necessity. The candidate has a strong background (theoretical and practical) in synthetic organic chemistry or synthetic medicinal chemistry.
Recommended expertise: Expertise in photochemistry is a strong pre. Expertise in medicinal chemistry on GPCRs is a pre.
Key publications:
- Hauwert et al., J. Am. Chem. Soc. 2018, 140, 4232
- Hauwert et al., Angew. Chem. Intl. Ed. 2019, 58, 4531
- Gómez-Santacana et al., Angew. Chem. Intl. Ed. 2018, 57, 11608
- Gómez-Santacana et al., Beilstein Arch. 2019, doi:10.3762/bxiv.2019.69.v1
For more information:
Prof. Dr. Rob Leurs – r.leurs@vu.nl
Prof. Dr. Iwan de Esch – i.de.esch@vu.nl
Dr. Maikel Wijtmans – m.wijtmans@vu.nl
Application:
Follow us on
My project will be focused on the role of #CXCR4/ACKR3/GRK2 -governed networks in cancer cell migration and metastasis.
New review on #gpcr structural dynamics out in COSB. Great teamwork with the @JanaSelent group. Thanks to @Lundbeckfonden and @novonordiskfond https://lnkd.in/eyjrA5V
A reminder that applications for our new Deputy Editor in Chief of #PharmacologyMatters close on Monday. https://buff.ly/2PNWf4V
ONCORNET2.0 is the successor to #ONCORNET. You can see some of the work of ESRs from the first ONCORNET in this special issue of @MolPharmJournal from 2019, with reviews on #CXCR4 and #ACKR3 structure and function: https://molpharm.aspetjournals.org/content/96/6
Hi everyone – we’re on Twitter! ONCORNET2.0 is a #MarieCurie ITN of 16 ESRs across Europe studying #chemokine #GPCRs #CXCR4 and #ACKR3 in cancer. Our projects cover molecular dynamics, medchem, #pharmacology through to translational work. Follow us for updates from our ESRs!
Contact details
Please contact us at:
info@oncornet.eu
ONCORNET Coordinator
VU University Amsterdam
The Netherlands